Loading...
Uploaded by ndtvprofit on May 20, 2010
Midcap pharma company Jubilant Organosys is very bullish on its specialty pharmaceuticals business. The company believes that driving the growth in this segment will be Radio Pharmaceuticals.
News & Politics
Standard YouTube License
Load more suggestions
All Comments